No photo of Miguel Chillón Rodriguez
  • Edifici M planta 1ª torre M1

    08193 Bellaterra (Cerdanyola del Vallès)

  • 3534 Citations
  • 29 h-Index
1989 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

Ph. D.

Award Date: 20 Jun 1994

Degree

Award Date: 30 Jun 1988

External positions

Miembro Consejo Direccion, Nanotherapix SL

1 Apr 2010 → …

Miembro del Comite de Seguridad Biológica

1 Jun 2006 → …

Responsable Científico

1 Jan 2003 → …

Profesor Investigación ICREA

1 Oct 2001 → …

Investigador postdoctoral Reincorporado

1 Jan 200030 Sep 2001

Investigador postdoctoral EMBO

1 Sep 199731 Dec 1999

Investigador postdoctoral HHMI

1 Jul 199431 Jul 1997

Fingerprint Dive into the research topics where Miguel Chillón Rodriguez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

  • 3534 Citations
  • 29 h-Index
  • 77 Article
  • 8 Chapter
  • 2 Review article
  • 1 Book

Secreted αKlotho isoform protects against age-dependent memory deficits

Massó, A., Sánchez, A., Bosch, A., Giménez-Llort, L. & Chillón, M., 1 Sep 2018, In : Molecular Psychiatry. 23, 9

Research output: Contribution to journalArticleResearchpeer-review

  • 17 Citations (Scopus)

    Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor

    Miralles, M., Eixarch, H., Tejero, M., Costa, C., Hirota, K., Castaño, A. R., Puig, M., Stockinger, G., Montalban, X., Bosch, A., Espejo, C. & Chillon, M., 1 Oct 2017, In : Neurotherapeutics. 14, 4, p. 1095-1106 12 p.

    Research output: Contribution to journalArticleResearchpeer-review

    Open Access
  • 6 Citations (Scopus)

    AAVrh.10 immunogenicity in mice and humans. Relevance of antibody cross-reactivity in human gene therapy

    Thwaite, R., Pagès, G., Chillón, M. & Bosch, A., 1 Jan 2015, In : Gene Therapy. 22, 2, p. 196-201

    Research output: Contribution to journalArticleResearchpeer-review

  • 34 Citations (Scopus)

    AAVrh.10 immunogenicity in mice and humans. Relevance of antibody cross-reactivity in human gene therapy.

    Thwaite, R., Pagès, G., Chillón, M. & Bosch, A., 1 Jan 2015, In : Gene Therapy. 2, p. 196-211

    Research output: Contribution to journalArticleResearch

    34 Citations (Scopus)

    Development of a rapid, robust, and universal PicoGreen-based method to titer adeno-associated vectors

    Piedra, J., Ontiveros, M., Miravet, S., Penalva, C., Monfar, M. & Chillon, M., 1 Jan 2015, In : Human gene therapy methods. 26, 1, p. 35-42

    Research output: Contribution to journalArticleResearchpeer-review

  • 27 Citations (Scopus)